Alimera Sciences Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
46,229.00
35,910.00
30,645.00
33,174.00
22,001.00
16,382
Depreciation, Depletion & Amortization
138.00
659.00
2,555.00
2,767.00
2,684.00
2,645
Other Funds
14,338.00
5,015.00
6,859.00
6,008.00
6,238.00
7,084
Funds from Operations
31,753.00
30,236.00
35,172.00
24,612.00
13,171.00
7,306
Changes in Working Capital
6,068.00
5,935.00
10,192.00
487.00
297.00
4,247
Net Operating Cash Flow
37,821.00
24,301.00
45,364.00
25,099.00
12,874.00
11,553
Capital Expenditures
973.00
25,842.00
451.00
186.00
238.00
Net Investing Cash Flow
973.00
25,842.00
451.00
186.00
238.00
Issuance/Reduction of Debt, Net
4,698.00
28,867.00
293.00
227.00
182.00
Net Financing Cash Flow
1,654.00
114,745.00
662.00
25,418.00
5,720.00
Net Change in Cash
36,936.00
64,069.00
45,585.00
102.00
6,915.00
Free Cash Flow
38,794.00
25,143.00
45,815.00
25,285.00
13,112.00
Deferred Taxes & Investment Tax Credit
-
-
223.00
213.00
92.00
653
Change in Capital Stock
125.00
85,878.00
1,219.00
26,714.00
5,902.00
Exchange Rate Effect
204.00
533.00
432.00
235.00
477.00
About Alimera Sciences
View Profile
